To describe the incidence and mortality of adult head and neck cancer (HNC) in different regions worldwide and their temporal trends.

Objective To investigate the effects and mechanisms of supplemented Buyang Huanwu decoction(BYHWD)on zinc home-ostasis and reproductive function in oligoasthenozoospermia(OAS)rats.Methods As many as 60 male SD rats were randomly divided into control,OAS,L-carnitine(0.323 g/kg),BYHWD low-dose(BYHWD-L,19.5 g/kg),BYHWD medium-dose(BYHWD-M,39 g/kg),and BYHWD high-dose(BYHWD-H,78 g/kg)groups,with 10 rats in each group.Except for the control group,all other groups were admini-stered adenine by gavage to establish an OAS model.After successful construction of the model,each group was treated by gavage with the corresponding drug doses or physiological saline once daily for 4 weeks.The general condition of the rats was recorded,testicular and epididymal coefficients were calculated,and sperm water volume and vitality were measured.Enzyme linked immunosorbent assay(ELISA)was used to measure the levels of serum testosterone(T),estradiol(E2),follicle-stimulating hormone(FSH),luteinizing hormone(LH),prolactin(PRL),as well as the levels of interleukin-1β(IL-1β),interleukin-6(IL-6),tumor necrosis factor α(TNF-α)and zinc containing enzymes alcohol dehydrogenase(ADH),alkaline phosphatase(ALP),and lactate dehydrogenase(LDH)in testicular tissue.The zinc con-tent in testicular tissue were also measured.Pathological changes in testicular tissue were observed using hematoxylin eosin(HE)staining.Toll-like receptor 4(TLR4),myeloid differentiation factor 88(MyD88),and nuclear factor kappa-B(NF-κB)protein expression in testicu-lar tissue were identified using immunohistochemistry.Results Compared to the control group,the OAS group exhibited significantly lower testicular and epididymal coefficients,sperm motility,sperm count,serum T and E2 levels(P＜0.05)and significantly higher FSH,LH,and PRL levels(P＜0.05).Furthermore,the OAS group showed significantly lower testicular tissue zinc content and levels of zinc containing enzymes ADH,ALP,and LDH(P＜0.05)than the control group.Conversely,IL-1β,IL-6,and TNF-α levels,along with protein expressions of TLR4,MyD88,and NF-κB were significantly higher in the OAS group than in the control group(P＜0.05).Compared to the OAS group,each drug intervention group showed improvements in testicular and epididymal coefficients,sperm motility,sperm count,T and E2 levels,testicular zinc content and zinc containing enzymes(ADH,ALP,and LDH)levels.Furthermore,the intervention groups demonstrated reduced FSH,LH,PRL,IL-1β,IL-6,and TNF-α levels,and TLR4/MyD88/NF-κB signaling pathway protein expression(P＜0.05).Conclusion BYHWD improves the reproductive function of OAS rats,potentially by regulating zinc homeostasis and TLR4/MyD88/NF-κB signaling pathway,consequently reducing the inflammatory response.

In recent years, 7-tesla high-resolution magnetic resonance imaging (7 T HR-MRI) has demonstrated significant advantages in evaluating intracranial atherosclerotic plaques due to its ultrahigh signal-to-noise ratio and submillimeter isotropic spatial resolution. This cutting-edge technique enables precise visualization of plaque microstructures, including morphological characteristics and compositional features. Moreover, it allows noninvasive in vivo imaging of small intracranial vessels and provides clear delineation of the anatomical relationship between perforating artery ostia and their parent arteries. Although not yet widely adopted in clinical practice, 7 T HR-MRI shows promising potential for plaque vulnerability assessment, stroke mechanism elucidation, and therapeutic monitoring. This review summarizes recent advancements in 7 T MRI applications for intracranial atherosclerotic disease, aiming to provide novel insights for precision medicine in clinical practice.

Objective To investigate the effects and mechanisms of supplemented Buyang Huanwu decoction(BYHWD)on zinc home-ostasis and reproductive function in oligoasthenozoospermia(OAS)rats.Methods As many as 60 male SD rats were randomly divided into control,OAS,L-carnitine(0.323 g/kg),BYHWD low-dose(BYHWD-L,19.5 g/kg),BYHWD medium-dose(BYHWD-M,39 g/kg),and BYHWD high-dose(BYHWD-H,78 g/kg)groups,with 10 rats in each group.Except for the control group,all other groups were admini-stered adenine by gavage to establish an OAS model.After successful construction of the model,each group was treated by gavage with the corresponding drug doses or physiological saline once daily for 4 weeks.The general condition of the rats was recorded,testicular and epididymal coefficients were calculated,and sperm water volume and vitality were measured.Enzyme linked immunosorbent assay(ELISA)was used to measure the levels of serum testosterone(T),estradiol(E2),follicle-stimulating hormone(FSH),luteinizing hormone(LH),prolactin(PRL),as well as the levels of interleukin-1β(IL-1β),interleukin-6(IL-6),tumor necrosis factor α(TNF-α)and zinc containing enzymes alcohol dehydrogenase(ADH),alkaline phosphatase(ALP),and lactate dehydrogenase(LDH)in testicular tissue.The zinc con-tent in testicular tissue were also measured.Pathological changes in testicular tissue were observed using hematoxylin eosin(HE)staining.Toll-like receptor 4(TLR4),myeloid differentiation factor 88(MyD88),and nuclear factor kappa-B(NF-κB)protein expression in testicu-lar tissue were identified using immunohistochemistry.Results Compared to the control group,the OAS group exhibited significantly lower testicular and epididymal coefficients,sperm motility,sperm count,serum T and E2 levels(P＜0.05)and significantly higher FSH,LH,and PRL levels(P＜0.05).Furthermore,the OAS group showed significantly lower testicular tissue zinc content and levels of zinc containing enzymes ADH,ALP,and LDH(P＜0.05)than the control group.Conversely,IL-1β,IL-6,and TNF-α levels,along with protein expressions of TLR4,MyD88,and NF-κB were significantly higher in the OAS group than in the control group(P＜0.05).Compared to the OAS group,each drug intervention group showed improvements in testicular and epididymal coefficients,sperm motility,sperm count,T and E2 levels,testicular zinc content and zinc containing enzymes(ADH,ALP,and LDH)levels.Furthermore,the intervention groups demonstrated reduced FSH,LH,PRL,IL-1β,IL-6,and TNF-α levels,and TLR4/MyD88/NF-κB signaling pathway protein expression(P＜0.05).Conclusion BYHWD improves the reproductive function of OAS rats,potentially by regulating zinc homeostasis and TLR4/MyD88/NF-κB signaling pathway,consequently reducing the inflammatory response.

In recent years, 7-tesla high-resolution magnetic resonance imaging (7 T HR-MRI) has demonstrated significant advantages in evaluating intracranial atherosclerotic plaques due to its ultrahigh signal-to-noise ratio and submillimeter isotropic spatial resolution. This cutting-edge technique enables precise visualization of plaque microstructures, including morphological characteristics and compositional features. Moreover, it allows noninvasive in vivo imaging of small intracranial vessels and provides clear delineation of the anatomical relationship between perforating artery ostia and their parent arteries. Although not yet widely adopted in clinical practice, 7 T HR-MRI shows promising potential for plaque vulnerability assessment, stroke mechanism elucidation, and therapeutic monitoring. This review summarizes recent advancements in 7 T MRI applications for intracranial atherosclerotic disease, aiming to provide novel insights for precision medicine in clinical practice.

This article reviews the current status, assessment tools, influencing factors, and intervention measures of self-management behavior of intestinal symptoms in patients with rectal cancer undergoing anal preservation surgery, in order to provide reference for further research and nursing practice on self-management of intestinal symptoms after rectal cancer anal preservation.

Background::Breast cancer is ranked among the most prevalent malignancies in the Chinese female population. However, comprehensive reports detailing the latest epidemiological data and attributable disease burden have not been extensively documented.Methods::In 2018, high-quality cancer surveillance data were recorded in 700 population-based cancer registries in China. We extracted data on female breast cancers (International Classification of Diseases, Tenth Revision [ICD-10]: C50) and estimated the incidence and mortality in 2022 according to the baseline data and corresponding trends from 2010 to 2018. Pathological types were classified according to the ICD for Oncology, 3rd Edition codes. Disability-adjusted life years (DALYs) were calculated as the sum of the years of life lost (YLLs) and years lived with disability (YLDs).Results::In 2022, approximately 357,200 new female breast cancer cases and 75,000 deaths occurred in China, accounting for 15.59% and 7.94% of total new cancer cases and deaths, respectively. The age-standardized incidence rate (ASIR) was 33.04 per 100,000. When analyzed by pathological type, the ASIRs for papillary neoplasms, invasive breast carcinoma, rare and salivary gland-type tumors, and other types were 1.13, 29.79, 0.24, and 1.88 per 100,000, respectively. The age-standardized mortality rate (ASMR) was 6.10 per 100,000. A total of 2,628,000 DALYs were found to be attributable to female breast cancer in China, comprising 2,278,300 YLLs and 349,700 YLDs. The ASIR, ASMR, and age-standardized rate (ASR) for DALYs in urban areas were consistently higher than those in rural areas. We observed a four-fold increase in the ASIR and ASR for DALYs and an eight-fold increase in the ASMR among females over 55 years compared with those aged under 55 years.Conclusion::These data provide invaluable insights into the latest epidemiology of female breast cancer in China and highlight the urgency for disease prevention and control strategy formulation.

BACKGROUND: Neuroendocrine neoplasms (NENs) are rare tumors characterized by variable biology and delayed diagnosis. However, the nationwide epidemiology of NENs has never been reported in China. We aimed to estimate the incidence and survival statistics of NENs in China, in comparison to those in the United States during the same period. METHODS: Based on the data from 246 population-based cancer registries covering 272.5 million people of China, we calculated age-specific incidence on NENs in 2017 and multiplied by corresponding national population to estimate the nationwide incidence in China. The data of 22 population-based cancer registries were used to estimate the trends of NENs incidence from 2000 to 2017 through the Joinpoint regression model. We used the cohort approach to analyze the 5-year age-standardized relative survival by sex, age group, and urban-rural area between 2008 and 2013, based on data from 176 high-quality cancer registries. We used data from the Surveillance, Epidemiology, and End Results (SEER) 18 program to estimate the comparable incidence and survival of NENs in the United States. RESULTS: The overall age-standardized rate (ASR) of NENs incidence was lower in China (1.14 per 100,000) than in the United States (6.26 per 100,000). The most common primary sites were lungs, pancreas, stomach, and rectum in China. The ASRs of NENs incidence increased by 9.8% and 3.6% per year in China and the United States, respectively. The overall 5-year relative survival in China (36.2%) was lower than in the United States (63.9%). The 5-year relative survival was higher for female patients than male patients, and was higher in urban areas than in rural areas. CONCLUSIONS The disparities in burden of NENs persist across sex, area, age group, and site in China and the United States. These findings may provide a scientific basis on prevention and control of NENs in the two countries.
Humans ; Male ; Female ; United States/epidemiology* ; Incidence ; Neuroendocrine Tumors/pathology* ; Neoplasms/epidemiology* ; Registries ; Urban Population ; China/epidemiology*

Objective:To estimate the incidence and mortality of corpus uteri cancer in China, 2015.Methods:Quality audit and evaluation of the data from 2015 cancer registration reported by 501 cancer registries were conducted, and 368 cancer registries were included in the analysis. The incidence rate and mortality rate of corpus uteri cancer were calculated according to the factors of the region (urban, rural, east, central, western), sex and age groups. The incidence and mortality of corpus uteri cancer with the 2015 population were estimated. Chinese standard population in 2000 and world Segi′s population were used for the calculation of age-standardized rates (ASR) of incidence and mortality.Results:In 2015, 368 cancer registries included in the analysis covered a total of 309 553 499 populations in China, accounting for 22.52% of the national population. It is estimated that there were about 68 900 new cases of corpus uteri cancer in 2015, the incidence rate was 10.28/10 5, age-standardized incidence rates by Chinese standard population (ASR China) and world standard population (ASR world) were 6.86/10 5 and 6.66/10 5, respectively. The incidence rate of urban area (11.35/10 5) was higher than that of rural area (8.90/10 5), and the incidence of eastern region (12.12/10 5) was higher than the central region (9.94/10 5) and the western region (8.25/10 5). It is estimated that in 2015, there were about 16 000 deaths of corpus uteri cancer, the mortality rate was 2.39/10 5, ASR China was 1.49/10 5, ASR world was 1.47/10 5. The mortality in urban areas (2.40/10 5) is close to rural areas (2.39/10 5); the mortality in central areas (2.55/10 5) was higher than the eastern areas (2.32/10 5) and the western areas (2.31/10 5). Conclusions:In China, the incidence of corpus uteri cancer is on the rise and has a trend of youth, the burden of disease is gradually increasing, which threatens the health of women. Targeted prevention and control measures should be carried out in the different regions.

Objective:To estimate the incidence and mortality of corpus uteri cancer in China, 2015.Methods:Quality audit and evaluation of the data from 2015 cancer registration reported by 501 cancer registries were conducted, and 368 cancer registries were included in the analysis. The incidence rate and mortality rate of corpus uteri cancer were calculated according to the factors of the region (urban, rural, east, central, western), sex and age groups. The incidence and mortality of corpus uteri cancer with the 2015 population were estimated. Chinese standard population in 2000 and world Segi′s population were used for the calculation of age-standardized rates (ASR) of incidence and mortality.Results:In 2015, 368 cancer registries included in the analysis covered a total of 309 553 499 populations in China, accounting for 22.52% of the national population. It is estimated that there were about 68 900 new cases of corpus uteri cancer in 2015, the incidence rate was 10.28/10 5, age-standardized incidence rates by Chinese standard population (ASR China) and world standard population (ASR world) were 6.86/10 5 and 6.66/10 5, respectively. The incidence rate of urban area (11.35/10 5) was higher than that of rural area (8.90/10 5), and the incidence of eastern region (12.12/10 5) was higher than the central region (9.94/10 5) and the western region (8.25/10 5). It is estimated that in 2015, there were about 16 000 deaths of corpus uteri cancer, the mortality rate was 2.39/10 5, ASR China was 1.49/10 5, ASR world was 1.47/10 5. The mortality in urban areas (2.40/10 5) is close to rural areas (2.39/10 5); the mortality in central areas (2.55/10 5) was higher than the eastern areas (2.32/10 5) and the western areas (2.31/10 5). Conclusions:In China, the incidence of corpus uteri cancer is on the rise and has a trend of youth, the burden of disease is gradually increasing, which threatens the health of women. Targeted prevention and control measures should be carried out in the different regions.